16.06.2020 16:46:55
|
Stock Alert: Biomerica Adds 14%
(RTTNews) - Shares of Biomerica, Inc. (BMRA) are rising more than 14% Tuesday morning after the company said it submitted Emergency Use Authorization (EUA) application to the FDA for its ELISA lab-based serology antibody test for Covid-19.
Biomerica has filed a provisional patent on technology to allow simplified blood collection.
The company also intends to obtain a CE mark to sell ELISA laboratory test outside the US.
BMRA is currently trading at $6.12. It has traded in the range of $2.05- $23.39 in the last 52 weeks.
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Biomerica IncShsmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Biomerica IncShsmehr Analysen
Aktien in diesem Artikel
Biomerica IncShs | 0,83 | 6,72% |
|